高级检索
当前位置: 首页 > 详情页

Single-cell sequencing and multiple machine learning algorithms to identify key T-cell differentiation gene for progression of NAFLD cirrhosis to hepatocellular carcinoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Dept Immuno Oncol, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Hosp Shijiazhuang 5, Div Liver Dis, Shijiazhuang, Hebei, Peoples R China [3]Hebei Med Univ, Hosp Shijiazhuang 5, Dept Pathol, Shijiazhuang, Hebei, Peoples R China [4]Hebei Med Univ, Immunol Dept, Shijiazhuang, Hebei, Peoples R China
出处:
ISSN:

关键词: NAFLD cirrhosis hepatocellular carcinoma single cell machine learning LDHA

摘要:
Introduction: Hepatocellular carcinoma (HCC), which is closely associated with chronicinflammation, is the most common liver cancer and primarily involves dysregulated immune responses in the precancerous microenvironment. Currently, most studies have been limited to HCC incidence. However, the immunopathogenic mechanisms underlying precancerous lesions remain unknown.Methods: We obtained single-cell sequencing data (GSE136103) from two nonalcoholic fatty liver disease (NAFLD) cirrhosis samples and five healthy samples. Using pseudo-time analysis, we systematically identified five different T-cell differentiation states. Ten machine-learning algorithms were used in 81 combinations to integrate the frameworks and establish the best T-cell differentiation-related prognostic signature in a multi-cohort bulk transcriptome analysis.Results: LDHA was considered a core gene, and the results were validated using multiple external datasets. In addition, we validated LDHA expression using immunohistochemistry and flow cytometry.Conclusion: LDHA is a crucial marker gene in T cells for the progression of NAFLD cirrhosis to HCC.

语种:
WOS:
PubmedID:
中科院分区:
出版当年[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化与分子生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 3 区 生化与分子生物学
JCR分区:
出版当年[2024]版:
最新[2023]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2023版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Dept Immuno Oncol, Shijiazhuang, Hebei, Peoples R China [2]Hebei Med Univ, Hosp Shijiazhuang 5, Div Liver Dis, Shijiazhuang, Hebei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Dept Immuno Oncol, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:39770 今日访问量:0 总访问量:1333 更新日期:2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 河北医科大学第四医院 技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号